Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Epidemiology, transmission, and pathogenesis of avian influenza

INTRODUCTION

There have been five influenza pandemics during the past 100 years, and each has been caused by the emergence of a novel virus. In the 1957 and 1968 pandemics, the new viruses contained components of previous human, as well as avian, influenza viruses. The origin of the influenza virus responsible for the 1918 pandemic, which killed more people in a single year than the bubonic plague, remains uncertain, but it appears to have been an adapted avian influenza strain. The emergence of a novel H1N1 human-swine-avian reassortant virus in 2009 in North America started a new pandemic. (See "Epidemiology of influenza" and "Epidemiology of pandemic H1N1 influenza ('swine influenza')".)

Sporadic transmission of avian influenza H5N1 to more than 640 humans since 2003 has prompted concerns that conditions are suitable for the emergence of a pandemic [1-7]. Two features of recent avian influenza H5N1 outbreaks are striking: the predominance of children and young adults and the high mortality rate [5,6]. Estimates of potential global mortality related to pandemic avian influenza are as high as 62 million deaths [7].

Highly pathogenic avian H5N1 influenza viruses now appear to be endemic among bird and poultry populations in Eurasia [8]. Sporadic transmission to humans raises concern that the H5N1 virus may mutate or combine with genetic material from coinfecting human influenza viruses to generate a novel strain capable of sustained human-to-human transmission with pandemic potential. The World Health Organization (WHO) has described the potential threat from H5N1 as a "public health crisis."

The epidemiology, transmission, and pathogenesis of avian influenza will be reviewed here. The clinical manifestations, diagnosis, treatment, and prevention of avian influenza are discussed separately. (See "Clinical manifestations and diagnosis of avian influenza" and "Treatment and prevention of avian influenza" and "Avian influenza vaccines".)

The novel avian influenza A H7N9 virus is also reviewed separately. (See "Avian influenza A H7N9: Epidemiology, clinical manifestations, and diagnosis".)

                    

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Aug 2014. | This topic last updated: Feb 11, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Monto AS. The threat of an avian influenza pandemic. N Engl J Med 2005; 352:323.
  2. Levi J, Inglesby T, Working Group on Pandemic Influenza Preparedness. Working Group on Pandemic Influenza Preparedness: joint statement in response to Department of Health and Human Services Pandemic Influenza Plan. Clin Infect Dis 2006; 42:92.
  3. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, Abdel-Ghafar AN, Chotpitayasunondh T, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008; 358:261.
  4. World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO. http://www.who.int/influenza/human_animal_interface/HAI_Risk_Assessment/en/index.html (Accessed on December 20, 2013).
  5. Stöhr K. Avian influenza and pandemics--research needs and opportunities. N Engl J Med 2005; 352:405.
  6. Bartlett JG, Hayden FG. Influenza A (H5N1): will it be the next pandemic influenza? Are we ready? Ann Intern Med 2005; 143:460.
  7. Murray CJ, Lopez AD, Chin B, et al. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 2006; 368:2211.
  8. Capua I, Marangon S. Control of avian influenza in poultry. Emerg Infect Dis 2006; 12:1319.
  9. Stephenson I, Zambon M. The epidemiology of influenza. Occup Med (Lond) 2002; 52:241.
  10. Webster RG, Kendal AP, Gerhard W. Analysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparations. Virology 1979; 96:258.
  11. Webster RG, Wright SM, Castrucci MR, et al. Influenza--a model of an emerging virus disease. Intervirology 1993; 35:16.
  12. Kaye D, Pringle CR. Avian influenza viruses and their implication for human health. Clin Infect Dis 2005; 40:108.
  13. Tumpey TM, Basler CF, Aguilar PV, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005; 310:77.
  14. Taubenberger JK, Reid AH, Lourens RM, et al. Characterization of the 1918 influenza virus polymerase genes. Nature 2005; 437:889.
  15. Briand S, Fukuda K. Avian influenza A (H5N1) virus and 2 fundamental questions. J Infect Dis 2009; 199:1717.
  16. Yuen KY, Chan PK, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351:467.
  17. Katz JM, Lim W, Bridges CB, et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis 1999; 180:1763.
  18. Bender C, Hall H, Huang J, et al. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology 1999; 254:115.
  19. Bridges CB, Lim W, Hu-Primmer J, et al. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. J Infect Dis 2002; 185:1005.
  20. Webster RG, Govorkova EA. H5N1 influenza--continuing evolution and spread. N Engl J Med 2006; 355:2174.
  21. Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004; 363:617.
  22. Chen H, Smith GJ, Li KS, et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci U S A 2006; 103:2845.
  23. Tiensin T, Ahmed SS, Rojanasthien S, et al. Ecologic risk factor investigation of clusters of avian influenza A (H5N1) virus infection in Thailand. J Infect Dis 2009; 199:1735.
  24. L'vov DK, Shchelkanov MIu, Deriabin PG, et al. [Isolation of influenza A/H5N1 virus strains from poultry and wild birds in West Siberia during epizooty (July 2005) and their depositing to the state collection of viruses (August 8, 2005)]. Vopr Virusol 2006; 51:11.
  25. WHO - Influenza at the Human-Animal Interface (HAI) http://www.who.int/csr/disease/avian_influenza/en (Accessed on February 02, 2012).
  26. Oner AF, Bay A, Arslan S, et al. Avian influenza A (H5N1) infection in eastern Turkey in 2006. N Engl J Med 2006; 355:2179.
  27. Centers for Disease Control and Prevention (CDC). Cases of influenza A (H5N1)--Thailand, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:100.
  28. Hien TT, de Jong M, Farrar J. Avian influenza--a challenge to global health care structures. N Engl J Med 2004; 351:2363.
  29. Parry J. Officials report first Cambodian case of avian flu. BMJ 2005; 330:273.
  30. Enserink M. Avian influenza. More cases in Turkey, but no mutations found. Science 2006; 311:161.
  31. Yu H, Shu Y, Hu S, et al. The first confirmed human case of avian influenza A (H5N1) in Mainland China. Lancet 2006; 367:84.
  32. Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006; 355:2186.
  33. World Health Organization. Human infection with avian influenza A(H5N1) virus - update. http://www.who.int/csr/don/2014_01_09_h5n1/en/index.html (Accessed on January 13, 2014).
  34. Wang TT, Parides MK, Palese P. Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science 2012; 335:1463.
  35. Toner ES, Adalja AA, Nuzzo JB, et al. Assessment of serosurveys for H5N1. Clin Infect Dis 2013; 56:1206.
  36. Oner AF, Dogan N, Gasimov V, et al. H5N1 avian influenza in children. Clin Infect Dis 2012; 55:26.
  37. Guan Y, Poon LL, Cheung CY, et al. H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci U S A 2004; 101:8156.
  38. World Health Organization. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines http://www.who.int/influenza/resources/documents/characteristics_virus_vaccines/en/index.html (Accessed on February 02, 2012).
  39. Wu B, Wang C, Dong G, et al. New evidence suggests Southern China as a common source of multiple clusters of highly pathogenic H5N1 avian influenza virus. J Infect Dis 2010; 202:452.
  40. Chan PK, Lee N, Zaman M, et al. Determinants of antiviral effectiveness in influenza virus A subtype H5N1. J Infect Dis 2012; 206:1359.
  41. Kuiken T, Rimmelzwaan G, van Riel D, et al. Avian H5N1 influenza in cats. Science 2004; 306:241.
  42. Keawcharoen J, Oraveerakul K, Kuiken T, et al. Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis 2004; 10:2189.
  43. Thiry E, Zicola A, Addie D, et al. Highly pathogenic avian influenza H5N1 virus in cats and other carnivores. Vet Microbiol 2007; 122:25.
  44. Leschnik M, Weikel J, Möstl K, et al. Subclinical infection with avian influenza A (H5N1) virus in cats. Emerg Infect Dis 2007; 13:243.
  45. Songserm T, Amonsin A, Jam-on R, et al. Fatal avian influenza A H5N1 in a dog. Emerg Infect Dis 2006; 12:1744.
  46. Khuntirat BP, Yoon IK, Blair PJ, et al. Evidence for subclinical avian influenza virus infections among rural Thai villagers. Clin Infect Dis 2011; 53:e107.
  47. Powell TJ, Fox A, Peng Y, et al. Identification of H5N1-specific T-cell responses in a high-risk cohort in vietnam indicates the existence of potential asymptomatic infections. J Infect Dis 2012; 205:20.
  48. Peiris M, Yuen KY, Leung CW, et al. Human infection with influenza H9N2. Lancet 1999; 354:916.
  49. Influenza A(H9N2) in Hong Kong Special Administrative Region of China (SAR). 10 Dec 2003 http://www.who.int/csr/don/2003_12_10/en/ (Accessed on February 02, 2012).
  50. Wang M, Fu CX, Zheng BJ. Antibodies against H5 and H9 avian influenza among poultry workers in China. N Engl J Med 2009; 360:2583.
  51. Choi YK, Ozaki H, Webby RJ, et al. Continuing evolution of H9N2 influenza viruses in Southeastern China. J Virol 2004; 78:8609.
  52. Stephenson I, Nicholson KG, Wood JM, et al. Confronting the avian influenza threat: vaccine development for a potential pandemic. Lancet Infect Dis 2004; 4:499.
  53. Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004; 363:587.
  54. Fouchier RA, Schneeberger PM, Rozendaal FW, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 2004; 101:1356.
  55. Belser JA, Bridges CB, Katz JM, Tumpey TM. Past, present, and possible future human infection with influenza virus A subtype H7. Emerg Infect Dis 2009; 15:859.
  56. Bos ME, Te Beest DE, van Boven M, et al. High probability of avian influenza virus (H7N7) transmission from poultry to humans active in disease control on infected farms. J Infect Dis 2010; 201:1390.
  57. Centers for Disease Control and Prevention (CDC). Update: influenza activity--United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine. MMWR Morb Mortal Wkly Rep 2004; 53:547.
  58. Wei SH, Yang JR, Wu HS, et al. Human infection with avian influenza A H6N1 virus: an epidemiological analysis. Lancet Respir Med 2013; 1:771.
  59. Chen H, Yuan H, Gao R, et al. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study. Lancet 2014; 383:714.
  60. World Health Organization. Avian influenza A (H10N8). http://www.wpro.who.int/china/mediacentre/factsheets/h10n8/en/ (Accessed on February 11, 2014).
  61. World Health Organization. Avian influenza A (H10N8). http://www.wpro.who.int/china/mediacentre/factsheets/h10n8/en/index.html (Accessed on December 20, 2013).
  62. Jourdain E, Gauthier-Clerc M, Bicout DJ, Sabatier P. Bird migration routes and risk for pathogen dispersion into western Mediterranean wetlands. Emerg Infect Dis 2007; 13:365.
  63. Kilpatrick AM, Chmura AA, Gibbons DW, et al. Predicting the global spread of H5N1 avian influenza. Proc Natl Acad Sci U S A 2006; 103:19368.
  64. Tran TH, Nguyen TL, Nguyen TD, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350:1179.
  65. Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005; 352:333.
  66. WHO disease alerts: 5th April 2004. Avian influenza H7 human infections in Canada www.who.int/csr/don/2004_04_05/en/ (Accessed on February 02, 2012).
  67. Mounts AW, Kwong H, Izurieta HS, et al. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis 1999; 180:505.
  68. Zhou L, Liao Q, Dong L, et al. Risk factors for human illness with avian influenza A (H5N1) virus infection in China. J Infect Dis 2009; 199:1726.
  69. Dinh PN, Long HT, Tien NT, et al. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis 2006; 12:1841.
  70. Areechokchai D, Jiraphongsa C, Laosiritaworn Y, et al. Investigation of avian influenza (H5N1) outbreak in humans--Thailand, 2004. MMWR Morb Mortal Wkly Rep 2006; 55 Suppl 1:3.
  71. Myers KP, Olsen CW, Setterquist SF, et al. Are swine workers in the United States at increased risk of infection with zoonotic influenza virus? Clin Infect Dis 2006; 42:14.
  72. Myers KP, Setterquist SF, Capuano AW, Gray GC. Infection due to 3 avian influenza subtypes in United States veterinarians. Clin Infect Dis 2007; 45:4.
  73. Sedyaningsih ER, Isfandari S, Setiawaty V, et al. Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006. J Infect Dis 2007; 196:522.
  74. WHO. Avian influenza - situation in Indonesia - update 16 http://www.who.int/csr/don/2006_05_31/en/index.html (Accessed on February 02, 2012).
  75. Wang H, Feng Z, Shu Y, et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 2008; 371:1427.
  76. Hayden F, Croisier A. Transmission of avian influenza viruses to and between humans. J Infect Dis 2005; 192:1311.
  77. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353:1374.
  78. Aditama TY, Samaan G, Kusriastuti R, et al. Risk factors for cluster outbreaks of avian influenza A H5N1 infection, Indonesia. Clin Infect Dis 2011; 53:1237.
  79. de Jong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005; 352:686.
  80. Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 2007; 370:1137.
  81. Vong S, Ly S, Van Kerkhove MD, et al. Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus--Cambodia, 2006. J Infect Dis 2009; 199:1744.
  82. Seeing Terror Risk, U.S. Asks Journals to Cut Flu Study Facts. The New York Times. http://www.nytimes.com/2011/12/21/health/fearing-terrorism-us-asks-journals-to-censor-articles-on-virus.html (Accessed on December 26, 2011).
  83. Pavia AT. Laboratory creation of a highly transmissible H5N1 influenza virus: balancing substantial risks and real benefits. Ann Intern Med 2012; 156:463.
  84. Inglesby TV. Engineered H5N1: a rare time for restraint in science. Ann Intern Med 2012; 156:460.
  85. Fouchier RA, García-Sastre A, Kawaoka Y, et al. Pause on avian flu transmission research. Science 2012; 335:400.
  86. Osterholm MT, Henderson DA. Public health and biosecurity. Life sciences at a crossroads: respiratory transmissible H5N1. Science 2012; 335:801.
  87. Palese P. Don't censor life-saving science. Nature 2012; 481:115.
  88. Fouchier RA, Herfst S, Osterhaus AD. Public health and biosecurity. Restricted data on influenza H5N1 virus transmission. Science 2012; 335:662.
  89. Berns KI, Casadevall A, Cohen ML, et al. Policy: Adaptations of avian flu virus are a cause for concern. Nature 2012; 482:153.
  90. Perez DR. Public health and biosecurity. H5N1 debates: hung up on the wrong questions. Science 2012; 335:799.
  91. Faden RR, Karron RA. Public health and biosecurity. The obligation to prevent the next dual-use controversy. Science 2012; 335:802.
  92. Herfst S, Osterhaus AD, Fouchier RA. The future of research and publication on altered H5N1 viruses. J Infect Dis 2012; 205:1628.
  93. Bouvier NM. The science of security versus the security of science. J Infect Dis 2012; 205:1632.
  94. Osterholm MT, Relman DA. Creating a mammalian-transmissible A/H5N1 influenza virus: social contracts, prudence, and alternative perspectives. J Infect Dis 2012; 205:1636.
  95. Lipsitch M, Plotkin JB, Simonsen L, Bloom B. Evolution, safety, and highly pathogenic influenza viruses. Science 2012; 336:1529.
  96. Frankel MS. Regulating the boundaries of dual-use research. Science 2012; 336:1523.
  97. Fauci AS, Collins FS. Benefits and risks of influenza research: lessons learned. Science 2012; 336:1522.
  98. Wolinetz CD. Implementing the new U.S. dual-use policy. Science 2012; 336:1525.
  99. Morens DM, Subbarao K, Taubenberger JK. Engineering H5N1 avian influenza viruses to study human adaptation. Nature 2012; 486:335.
  100. Despite safety worries, work on deadly flu to be released. The New York Times. http://www.nytimes.com/2012/02/18/health/details-of-bird-flu-research-will-be-released.html?_r=1&emc=eta1 (Accessed on February 22, 2012).
  101. Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012; 486:420.
  102. Yong E. Mutant-flu paper published. Nature 2012; 485:13.
  103. Herfst S, Schrauwen EJ, Linster M, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 2012; 336:1534.
  104. Russell CA, Fonville JM, Brown AE, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 2012; 336:1541.
  105. Cheung CY, Poon LL, Lau AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002; 360:1831.
  106. Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005; 6:135.
  107. Zhou J, Law HK, Cheung CY, et al. Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J Infect Dis 2006; 194:61.
  108. Lee SM, Cheung CY, Nicholls JM, et al. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis 2008; 198:525.
  109. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12:1203.
  110. Perrone LA, Szretter KJ, Katz JM, et al. Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. J Infect Dis 2010; 202:1161.
  111. Belser JA, Zeng H, Katz JM, Tumpey TM. Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infection. J Infect Dis 2011; 203:40.
  112. Yao L, Korteweg C, Hsueh W, Gu J. Avian influenza receptor expression in H5N1-infected and noninfected human tissues. FASEB J 2008; 22:733.
  113. Nicholls JM, Bourne AJ, Chen H, et al. Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res 2007; 8:73.
  114. Shinya K, Ebina M, Yamada S, et al. Avian flu: influenza virus receptors in the human airway. Nature 2006; 440:435.
  115. Munster VJ, de Wit E, van Riel D, et al. The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis 2007; 196:258.
  116. van Riel D, Munster VJ, de Wit E, et al. H5N1 Virus Attachment to Lower Respiratory Tract. Science 2006; 312:399.
  117. Nicholls JM, Chan MC, Chan WY, et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 2007; 13:147.
  118. Auewarakul P, Suptawiwat O, Kongchanagul A, et al. An avian influenza H5N1 virus that binds to a human-type receptor. J Virol 2007; 81:9950.
  119. Yamada S, Suzuki Y, Suzuki T, et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 2006; 444:378.
  120. Rimmelzwaan GF, van Riel D, Baars M, et al. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol 2006; 168:176.
  121. Maines TR, Lu XH, Erb SM, et al. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol 2005; 79:11788.
  122. Human cases of avian influenza A (H5N1). MMWR Morb Mortal Wkly Rep 2006; 55:76.
  123. To KF, Chan PK, Chan KF, et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 2001; 63:242.
  124. Rimmelzwaan GF, Kuiken T, van Amerongen G, et al. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol 2001; 75:6687.
  125. Shu Y, Li CK, Li Z, et al. Avian influenza A(H5N1) viruses can directly infect and replicate in human gut tissues. J Infect Dis 2010; 201:1173.